Rachel A. Lindor

Papers

Total Citations

H-Index

About

Rachel A. Lindor is a prominent scholar at the intersection of law, medicine, and bioethics, whose work critically examines the legal and ethical implications of emerging genetic technologies. Her most-cited paper, "Personalized Medicine and Genetic Malpractice" (2013, 31 citations), has become a foundational text in the field, pioneering the discussion of how personalized genomic medicine reshapes standards of care and liability in medical malpractice. Lindor’s research explores the tension between rapid scientific advancement and existing legal frameworks, particularly focusing on the duty of physicians to disclose genetic risks and the potential for "genetic malpractice" claims. Her contributions have been instrumental in shaping policy debates around informed consent, privacy, and the regulation of direct-to-consumer genetic testing. By bridging clinical genetics with legal scholarship, Lindor has provided a roadmap for courts and legislators grappling with the complexities of precision medicine. Her work is widely cited by legal scholars, bioethicists, and healthcare practitioners, reflecting its profound impact on how we understand the responsibilities of medical professionals in the age of genomics.